DBCO-Val-Cit-PAB-MMAE
DBCO-Val-Cit-PAB-MMAE is a drug-linker conjugate, which can be used for the synthesis of ADC molecules. MMAE (HY-15162) is a tubulin inhibitor, which can be used as an ADC toxin. DBCO-Val-Cit-PAB is the linker with the electrophilic group[1].
Product Specifications
UNSPSC
12352203
Hazard Statement
H302, H315, H319, H335
Target
Drug-Linker Conjugates for ADC
Type
ADC Related
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dbco-val-cit-pab-mmae.html
Purity
98.33
Solubility
DMSO : 33.33 mg/mL (ultrasonic)
Smiles
Molecular Formula
C77H107N11O14
Molecular Weight
1410.74
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture and light)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-W591408/DBCO-Val-Cit-PAB-MMAE-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-W591408/DBCO-Val-Cit-PAB-MMAE-SDS-MedChemExpress.pdf
Scientific Category
ADC Related
Clinical Information
No Development Reported
CAS Number
[2768446-73-5]
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items